Answers are grounded in this paper and cite their sources.
Expert perspective outlines challenges in patient-derived stem cell models of brain disorders, highlighting critical technical hurdles for drug discovery.
As a group, we met to discuss the current challenges for creating meaningful patient-specific in vitro models to study brain disorders. Although the convergence of findings between laboratories and patient cohorts provided us confidence and optimism that hiPSC-based platforms will inform future drug discovery efforts, a number of critical technical challenges remain. This opinion piece outlines our collective views on the current state of hiPSC-based disease modeling and discusses what we see to be the critical objectives that must be addressed collectively as a field.
No takes yet. Share an insight, caveat, or question.
Brennand et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: